Atlas Trials

Investigation of Intranasal Ketamine Related Changes in Attentional Brain Networks With Functional and Structural MRI

Clinical trial NCT05320120 · COMPLETED

Trial details

NCT number
NCT05320120
Sponsor
Rupert Lanzenberger
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ketamine Treatment
Start date
2022-06-01
Primary completion
2023-06-21
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.